Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesco Bassani
Observed names:
F Bassani,
F. Bassani
Institutions:
Azienda Ospedaliera Ospedale Civile di Legnano,
Aziende Socio Sanitarie Territoriale Ovest Milanese
Observed institutions:
University of Milan,
Azienda Ospedaliera Ospedale Civile di Legnano,
Aziende Socio Sanitarie Territoriale Ovest Milanese
ORCID:
0009-0001-7002-7044
Observed ORCID:
0009-0001-7002-7044
OpenAlex ID:
A5079932593
Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective Study
2023
·
Gabriele Pagani
, Marco Parenti
, et al.
·
Pathogens
·
9
PDF
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry
2025
·
Tommaso Clemente
, Golnaz Torkjazi
, et al.
·
Journal of Antimicrobial Chemotherapy
·
4
Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017–2023
2025
·
A.C. Ka’e
, F. Bassani
, et al.
·
Journal of Global Antimicrobial Resistance
·
2
‘Leaving no stones unturned’: up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort
2026
·
Arturo Ciccullo
, Gianmaria Baldin
, et al.
·
Journal of Antimicrobial Chemotherapy
·
1
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry
2025
·
D Armenia
, G Marchegiani
, et al.
·
Journal of Antimicrobial Chemotherapy
·
1
PDF
OC54 Ten years results on the effectiveness and safety of DTG+3TC as a switch regimen in the ODOACRE cohort
2025
·
A Ciccullo
, G Baldin
, et al.
·
Sexually Transmitted Infections
·
1
Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry
2026
·
Maria Mercedes Santoro
, Daniele Spalletta
, et al.
·
Journal of Antimicrobial Chemotherapy
PDF
OC38 Long-term effectiveness and tolerability of cabotegravir plus rilpivirine as a switch strategy in a multicenter Italian real-world cohort
2026
·
A Ciccullo
, G Baldin
, et al.
·
Sexually Transmitted Infections
SC21 Virological efficacy and tolerability of the long-acting regimen with rilpivirine and cabotegravir: a quest for the ideal candidate
2026
·
G Baldin
, A Ciccullo
, et al.
·
Sexually Transmitted Infections
PDF
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimens
2025
·
Francesca Lombardi
, Elio Gentilini Cacciola
, et al.
·
International Journal of Antimicrobial Agents
Safe Switch to an Oral Two‐Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV‐1: An Observational Multicenter Study
2025
·
Giulia Meraviglia
, Anna Sala
, et al.
·
Health Science Reports
PDF
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium species.
2025
·
Francesco Bassani
, Gabriele Pagani
, et al.
·
PubMed
Early Scedosporium apiospermium infection of a soil-contaminated traumatic injury successfully treated with isavuconazole: A case report
2025
·
Gabriele Pagani
, Francesco Bassani
, et al.
·
IDCases
SC-28 Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy according to subtype over the period 2017–2023
2024
·
AC Ka’e
, F Bassani
, et al.
·
Sexually Transmitted Infections
PDF
Show more works
View as search
Works count:
14
Citation count:
18
H-index:
2
I10-index:
Year
Topic
Type